Skip to content
OpenCapital
Get started

BridgeBio Pharma BBIO Impairment and restructuring

Impairment and restructuring at other companies

Sirius XM logo
Sirius XMSIRI
$6M-87.5%
Warner Bros. Discovery, Inc. logo
Warner Bros. Discovery, Inc.WBD
-$14M+84.4%
Xylem logo
XylemXYL
$500K0.0%
Watts Water Technologies, Inc. logo
Watts Water Technologies, Inc.WTS
$25K—
Micron Technology logo
Micron TechnologyMU
$0—
IDEX logo
IDEXIEX
——

Segments

By segment

See full
Reportable Segment$0—

Other financials

Income statement

See full
Revenue$194.5M+66.8%
Gross profit$184.6M+61.9%
Operating income-$106.0M-1.5%
Net income-$166.6M+1.8%
EPS (diluted)-$0.84+4.5%

Balance sheet

See full
Cash & equivalents$882.0M+62.5%
Total debt$3.3B+32,101%
Total equity-$2.3B-38.2%
Total assets$1.4B+55.5%

Cash flow

See full
Operating cash flow-$197.3M+1.0%
CapEx$69.0K—
Free cash flow-$197.3M+0.9%

Valuation

See full
Market cap$12.98B+119%
Enterprise value$15.36B+178%
P/S22.4×-24.1×

Profitability

See full
Gross margin95.1%-0.2pp
Operating margin-90.5%-41.2pp
Net margin-125.9%-54.5pp
FCF margin-76.8%—

Returns & leverage

See full
Return on equity-216.8%—
Debt / equity2×—
Current ratio1.5×-3.0×